Inventor
STERN DAVID M
US32 patents
⚠️ This page may combine multiple inventors who share the name “STERN DAVID M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV COLUMBIA
20 patentsUS5552267ASep 3, 1996
Solution for prolonged organ preservation
UNIV COLUMBIA234 citations97
US6825164B1Nov 30, 2004
Method to increase cerebral blood flow in amyloid angiopathy
UNIV COLUMBIA75 citations96
US5370989ADec 6, 1994
Solution for prolonged organ preservation
UNIV COLUMBIA143 citations96
US5641867AJun 24, 1997
Antibody which specifically binds to endothelial-monocyte activating polypeptide II
UNIV COLUMBIA51 citations93
US6790443B2Sep 14, 2004
Method for treating symptoms of diabetes
UNIV COLUMBIA37 citations92
US6563015B1May 13, 2003
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof
UNIV COLUMBIA31 citations92
US6268479B1Jul 31, 2001
Intracellular amyloid-beta peptide binding (ERAB) polypeptide
UNIV COLUMBIA32 citations92
US6228837B1May 8, 2001
Endothelial monocyte activating polypeptide II: a mediator which activates host response
UNIV COLUMBIA28 citations90
US7258857B2Aug 21, 2007
Rage-related methods for treating inflammation
UNIV COLUMBIA42 citations89
US5968911AOct 19, 1999
Method of inducing vasorelaxation to treat pulmonary hypertension
UNIV COLUMBIA26 citations89
US5728705AMar 17, 1998
Method of inducing vasorelaxation to treat pulmonary hypertension
UNIV COLUMBIA30 citations89
US5426097AJun 20, 1995
Calreticulin: a novel antithrombotic agent
UNIV COLUMBIA35 citations88
US7732400B2Jun 8, 2010
Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
UNIV COLUMBIA16 citations87
US6969704B1Nov 29, 2005
Methods for suppressing early growth response—1protein (Egr-1) to reduce vascular injury in a subject
UNIV COLUMBIA49 citations87
US7700085B2Apr 20, 2010
Method for treating symptoms of diabetes
UNIV COLUMBIA8 citations84
US6994974B1Feb 7, 2006
Intracellular amyloid-beta binding (ERAB) polypeptide-related assays
UNIV COLUMBIA12 citations84
US6891081B1May 10, 2005
Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereof
UNIV COLUMBIA14 citations84
US6734168B2May 11, 2004
Endothelial monocyte activating polypeptide II: a mediator which activates host response
UNIV COLUMBIA11 citations71
US7919670B1Apr 5, 2011
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof
UNIV COLUMBIA4 citations62
US7060870B1Jun 13, 2006
Transgenic mice over-expressing ABAD and mutant APP in brain as model of Alzheimer's disease and uses thereof
UNIV COLUMBIA2 citations62
DREXELBROOK ENG CO
3 patentsDREXELBROOK CONTROLS
2 patentsSTERN DAVID M
2 patentsUS8124829B2Feb 28, 2012
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof
STERN DAVID M3 citations60
US8133866B2Mar 13, 2012
Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
STERN DAVID M1 citations44